High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients with High-risk Stage 3 Neuroblastoma: 10-Year Experience at a Single Center

High-dose chemotherapy and autologous stem cell rescue (HDCT/ASCR) was applied to improve the prognosis of patients with high-risk stage 3 neuroblastoma. From January 1997 to December 2006, 28 patients were newly diagnosed as stage 3 neuroblastoma. Nine of 11 patients with N-myc amplification and 5...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Suh, Jung Min, Yoo, Keon Hee, Sung, Ki Woong, Kim, Ju Youn, Cho, Eun Joo, Koo, Hong Hoe, Lee, Suk Koo, Kim, Jhingook, Lim, Do Hoon, Suh, Yeon Lim, Kim, Dae Won
التنسيق: Artigo
اللغة:Inglês
منشور في: The Korean Academy of Medical Sciences 2009
الموضوعات:
Original Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC2719186/
https://ncbi.nlm.nih.gov/pubmed/19654949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2009.24.4.660
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة